vs
Healthpeak Properties（DOC）与威德福国际（WFRD）财务数据对比。点击上方公司名可切换其他公司
威德福国际的季度营收约是Healthpeak Properties的1.6倍（$1.2B vs $702.9M），Healthpeak Properties净利率更高（51.6% vs 9.5%，领先42.2%），Healthpeak Properties同比增速更快（-6.6% vs -8.3%），过去两年Healthpeak Properties的营收复合增速更高（0.5% vs -9.5%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
威德福国际是一家美国跨国油田服务企业，总部位于美国，业务覆盖全球75个国家的油气产区，为油气井的钻探、评估、完井、生产及修井作业提供专业技术设备与相关服务，在全球油田服务领域拥有广泛布局。
DOC vs WFRD — 直观对比
营收规模更大
WFRD
是对方的1.6倍
$702.9M
营收增速更快
DOC
高出1.6%
-8.3%
净利率更高
DOC
高出42.2%
9.5%
两年增速更快
DOC
近两年复合增速
-9.5%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $702.9M | $1.2B |
| 净利润 | $363.0M | $109.0M |
| 毛利率 | — | — |
| 营业利润率 | 0.7% | 10.7% |
| 净利率 | 51.6% | 9.5% |
| 营收同比 | -6.6% | -8.3% |
| 净利润同比 | 28.3% | 42.1% |
| 每股收益（稀释后） | $0.28 | $1.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCWFRD
| Q1 26 | $702.9M | $1.2B | ||
| Q4 25 | $719.4M | $1.3B | ||
| Q3 25 | $705.9M | $1.2B | ||
| Q2 25 | $694.3M | $1.2B | ||
| Q1 25 | $702.9M | $1.2B | ||
| Q4 24 | $698.0M | $1.3B | ||
| Q3 24 | $700.4M | $1.4B | ||
| Q2 24 | $695.5M | $1.4B |
净利润DOCWFRD
| Q1 26 | $363.0M | $109.0M | ||
| Q4 25 | $114.0M | $138.0M | ||
| Q3 25 | $-117.1M | $81.0M | ||
| Q2 25 | $31.7M | $136.0M | ||
| Q1 25 | $42.8M | $76.0M | ||
| Q4 24 | $4.5M | $112.0M | ||
| Q3 24 | $85.9M | $157.0M | ||
| Q2 24 | $146.0M | $125.0M |
毛利率DOCWFRD
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 58.6% | — | ||
| Q2 25 | 60.2% | — | ||
| Q1 25 | 61.1% | — | ||
| Q4 24 | 60.3% | — | ||
| Q3 24 | 60.0% | — | ||
| Q2 24 | 60.6% | — |
营业利润率DOCWFRD
| Q1 26 | 0.7% | 10.7% | ||
| Q4 25 | 17.4% | 15.4% | ||
| Q3 25 | 9.2% | 14.4% | ||
| Q2 25 | 5.7% | 19.7% | ||
| Q1 25 | 7.7% | 11.9% | ||
| Q4 24 | -2.2% | 14.8% | ||
| Q3 24 | 14.1% | 17.2% | ||
| Q2 24 | 22.3% | 18.8% |
净利率DOCWFRD
| Q1 26 | 51.6% | 9.5% | ||
| Q4 25 | 73.2% | 10.7% | ||
| Q3 25 | -16.6% | 6.6% | ||
| Q2 25 | 4.6% | 11.3% | ||
| Q1 25 | 6.1% | 6.4% | ||
| Q4 24 | 0.7% | 8.4% | ||
| Q3 24 | 12.3% | 11.1% | ||
| Q2 24 | 21.0% | 8.9% |
每股收益（稀释后）DOCWFRD
| Q1 26 | $0.28 | $1.49 | ||
| Q4 25 | $0.16 | $1.91 | ||
| Q3 25 | $-0.17 | $1.12 | ||
| Q2 25 | $0.05 | $1.87 | ||
| Q1 25 | $0.06 | $1.03 | ||
| Q4 24 | $0.02 | $1.53 | ||
| Q3 24 | $0.12 | $2.06 | ||
| Q2 24 | $0.21 | $1.66 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $-1.2B | $1.0B |
| 总债务越低越好 | — | $1.5B |
| 股东权益账面价值 | $7.8B | $1.8B |
| 总资产 | $21.6B | — |
| 负债/权益比越低杠杆越低 | — | 0.84× |
8季度趋势，按日历期对齐
现金及短期投资DOCWFRD
| Q1 26 | $-1.2B | $1.0B | ||
| Q4 25 | $467.5M | $987.0M | ||
| Q3 25 | $91.0M | $967.0M | ||
| Q2 25 | $89.4M | $943.0M | ||
| Q1 25 | $70.6M | $873.0M | ||
| Q4 24 | $119.8M | $916.0M | ||
| Q3 24 | $180.4M | $920.0M | ||
| Q2 24 | $106.9M | $862.0M |
总债务DOCWFRD
| Q1 26 | — | $1.5B | ||
| Q4 25 | $9.8B | $1.5B | ||
| Q3 25 | $9.1B | $1.5B | ||
| Q2 25 | $9.0B | $1.6B | ||
| Q1 25 | $8.9B | $1.6B | ||
| Q4 24 | $8.7B | $1.6B | ||
| Q3 24 | $8.6B | $1.6B | ||
| Q2 24 | $8.6B | $1.6B |
股东权益DOCWFRD
| Q1 26 | $7.8B | $1.8B | ||
| Q4 25 | $7.5B | $1.7B | ||
| Q3 25 | $7.6B | $1.6B | ||
| Q2 25 | $7.9B | $1.5B | ||
| Q1 25 | $8.2B | $1.4B | ||
| Q4 24 | $8.4B | $1.3B | ||
| Q3 24 | $8.6B | $1.3B | ||
| Q2 24 | $8.8B | $1.2B |
总资产DOCWFRD
| Q1 26 | $21.6B | — | ||
| Q4 25 | $20.3B | $5.2B | ||
| Q3 25 | $19.6B | $5.3B | ||
| Q2 25 | $19.8B | $5.1B | ||
| Q1 25 | $19.8B | $5.1B | ||
| Q4 24 | $19.9B | $5.2B | ||
| Q3 24 | $20.0B | $5.2B | ||
| Q2 24 | $20.2B | $5.1B |
负债/权益比DOCWFRD
| Q1 26 | — | 0.84× | ||
| Q4 25 | 1.31× | 0.86× | ||
| Q3 25 | 1.20× | 0.94× | ||
| Q2 25 | 1.14× | 1.04× | ||
| Q1 25 | 1.08× | 1.17× | ||
| Q4 24 | 1.04× | 1.26× | ||
| Q3 24 | 1.00× | 1.21× | ||
| Q2 24 | 0.98× | 1.33× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $136.0M |
| 自由现金流经营现金流 - 资本支出 | — | $85.0M |
| 自由现金流率自由现金流/营收 | — | 7.4% |
| 资本支出强度资本支出/营收 | 3.4% | 4.7% |
| 现金转化率经营现金流/净利润 | — | 1.25× |
| 过去12个月自由现金流最近4个季度 | — | $470.0M |
8季度趋势，按日历期对齐
经营现金流DOCWFRD
| Q1 26 | — | $136.0M | ||
| Q4 25 | $1.3B | $268.0M | ||
| Q3 25 | $315.0M | $138.0M | ||
| Q2 25 | $363.5M | $128.0M | ||
| Q1 25 | $279.4M | $142.0M | ||
| Q4 24 | $1.1B | $249.0M | ||
| Q3 24 | $318.2M | $262.0M | ||
| Q2 24 | $316.2M | $150.0M |
自由现金流DOCWFRD
| Q1 26 | — | $85.0M | ||
| Q4 25 | $357.0M | $217.0M | ||
| Q3 25 | — | $94.0M | ||
| Q2 25 | — | $74.0M | ||
| Q1 25 | — | $65.0M | ||
| Q4 24 | $333.7M | $149.0M | ||
| Q3 24 | — | $184.0M | ||
| Q2 24 | — | $88.0M |
自由现金流率DOCWFRD
| Q1 26 | — | 7.4% | ||
| Q4 25 | 49.6% | 16.8% | ||
| Q3 25 | — | 7.6% | ||
| Q2 25 | — | 6.1% | ||
| Q1 25 | — | 5.4% | ||
| Q4 24 | 47.8% | 11.1% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | — | 6.3% |
资本支出强度DOCWFRD
| Q1 26 | 3.4% | 4.7% | ||
| Q4 25 | 124.4% | 4.0% | ||
| Q3 25 | — | 3.6% | ||
| Q2 25 | — | 4.5% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | 105.6% | 7.5% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | 4.4% |
现金转化率DOCWFRD
| Q1 26 | — | 1.25× | ||
| Q4 25 | 10.99× | 1.94× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | 11.48× | 0.94× | ||
| Q1 25 | 6.52× | 1.87× | ||
| Q4 24 | 235.43× | 2.22× | ||
| Q3 24 | 3.71× | 1.67× | ||
| Q2 24 | 2.17× | 1.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |
WFRD
| Middle East/North Africa/Asia | $476.0M | 41% |
| Europe/Sub-Sahara Africa/Russia | $233.0M | 20% |
| Latin America | $223.0M | 19% |
| North America | $220.0M | 19% |
